Global $725+ Bn Biomaterials Markets to 2031
October 12, 2021 07:48 ET
|
Research and Markets
Dublin, Oct. 12, 2021 (GLOBE NEWSWIRE) -- The "Biomaterials Market - A Global and Regional Analysis: Focus on Applications, Product Types, and Countries - Analysis and Forecast, 2021-2031" report...
Global Medical Collagen Market to 2028 - COVID-19 Impact and Analysis
May 25, 2021 05:18 ET
|
Research and Markets
Dublin, May 25, 2021 (GLOBE NEWSWIRE) -- The "Medical Collagen Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source, Product, and Application" report has been added to...
Worldwide Orthopedic Biomaterials Industry to 2030 - Players Include Zimmer Biomet Holdings, Stryker and Globus Medical Among Others
April 07, 2021 04:43 ET
|
Research and Markets
Dublin, April 07, 2021 (GLOBE NEWSWIRE) -- The "Orthopedic Biomaterials Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to...
Global Biomaterials Market (2020 to 2025) - by Product, Material Type, Type, Application, End-user and Region
November 13, 2020 04:23 ET
|
Research and Markets
Dublin, Nov. 13, 2020 (GLOBE NEWSWIRE) -- The "Global Biomaterials Market By Product (Implants, Valves, Joint Replacement, Contact Lenses and Others), By Material Type (Metallic, Natural, Ceramics,...
CURE Pharmaceutical Secures Patent on Oral Thin Film Containing Bioactive Cannabinoid Molecules
May 22, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the issuance of U.S. Patent No. 10,307,397,...
Emerald Health Therapeutics Closes Emerald Health Naturals Joint Venture
January 10, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) is pleased to announce that, further to its news releases dated...
Emerald Health Therapeutics Receives TSX Venture Conditional Approval of Emerald Health Naturals Joint Venture
November 19, 2018 07:00 ET
|
Emerald Health Therapeutics Inc.
Joint venture to distribute endocannabinoid-supporting products to Canadian natural health product stores and pharmacies VICTORIA, British Columbia, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Emerald...
CURE Pharmaceutical Secures Patent for Oral Thin Film Containing Bioactive Cannabinoid Molecules
September 25, 2018 08:45 ET
|
CURE Pharmaceutical
LOS ANGELES, Sept. 25, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, announced the allowance of an oral thin film patent (U.S. Patent...
CURE Pharmaceutical Secures Two Patents for the Extraction and Purification of Bioactive Cannabinoid Molecules
April 04, 2018 08:57 ET
|
CURE Pharmaceutical
LOS ANGELES, April 04, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the acquisition of two patents that ensure CURE...